Valuation
- Market cap
- —
- Revenue TTM
- $0
- Net income TTM
- $0
- P/E (trailing)
- —
- P/E (forward)
- —
- Profit margin
- 0.00%
- Debt to equity
- —
Trading
- Volume
- 400
- Avg volume
- —
- Day's range
- $0.10 – $0.10
- Shares out
- —
- Stochastic %K
- —
- Beta
- —
- Analysts
- —
- Price target
- —
Company profile
Coiled Therapeutics plc, a clinical stage oncology company, develops precision oncology therapies. It develops AO-252, a TACC3 inhibitor that is in Phase I clinical trials; and STAT-6 siRNA program, which is in preclinical trials for treating immunology indications. The company is based in London, United Kingdom.
- Industry
- Biotechnology
- Sector
- Healthcare
- Phone
- 44 20 3918 8633
- Website
- https://coiledplc.com
- Address
- 85 Great Portland Street, First Floor, London, United Kingdom
Latest news
No headlines yet.
